DOI QR코드

DOI QR Code

A Case of Hyperamylasemia Associated with Lung Adenocarcinoma

고아밀라제혈증을 보인 폐선암 1예

  • Lee, Myung-Hyun (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Ko, Sun-Young (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Park, Kyun-Woo (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Kim, Jung-Hoon (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Woo, In-Sook (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Han, Chi-Wha (Department of Internal Medicine, The Catholic University of Korea College of Medicine) ;
  • Heo, Ju-Yeon (Department of Internal Medicine, The Catholic University of Korea College of Medicine)
  • 이명현 (가톨릭대학교 의과대학 내과학교실) ;
  • 고선영 (가톨릭대학교 의과대학 내과학교실) ;
  • 박건우 (가톨릭대학교 의과대학 내과학교실) ;
  • 김정훈 (가톨릭대학교 의과대학 내과학교실) ;
  • 우인숙 (가톨릭대학교 의과대학 내과학교실) ;
  • 한치화 (가톨릭대학교 의과대학 내과학교실) ;
  • 허주연 (가톨릭대학교 의과대학 내과학교실)
  • Published : 2012.04.01

Abstract

Hyperamylasemia in patients with lung cancer is relatively rare, occurring in 1-3% of all cases of the disease. The pathogenesis of hyperamylasemia in solid cancers is not clear. In Korea, no cases of hyperamylasemia have been reported in patients with adenocarcinoma of the lung. Instead, the lung cancers in patients with hyperamylasemia have in most cases been adenocarcinomas. We report a case of a 64-year-old woman with hyperamylasemia that was suspected to have been induced by mucinous adenocarcinoma of the lung. The patient' amylase isoenzyme pattern was of the salivary type. Systemic chemotherapy normalized her serum amylase levels and produced a partial response in her lung cancer.

종양세포에 의한 혈중 아밀라제의 증가는 드물다고 보고되고 있으며 이소성 아밀라제를 생성하는 종양 중 가장 많은 것은 폐암이며, 그중 조직학적으로 선암이 가장 많은 비중을 차지하고 있다. 국내 보고에서는 고아밀라제 혈증을 동반한 소세포성 폐암 및 편평상피세포 폐암에서의 증례가 각각 한 예씩 있었으나 폐선암에서의 고아밀라제 혈증이 동반된 예는 국내에서 보고된 바가 없어 이를 문헌고찰과 함께 보고하는 바이다.

Keywords

References

  1. Shimamura J, Fridhandler L, Berk JE. Nonpancreatic-type hyperamylasemia associated with pancreatic cancer. Am J Dig Dis 1976;21:340-345. https://doi.org/10.1007/BF01071849
  2. Moriyama T. Sialyl salivary-type amylase associated with ovarian cancer. Clin Chim Acta 2008;391:106-111. https://doi.org/10.1016/j.cca.2008.01.025
  3. Berk JE, Shimamura J, Fridhandler L. Tumor-associated hyperamylasemia. Am J Gastroenterol 1977;68:572-577.
  4. Colaut F, Toniolo L, Sperti C, Pozzobon M, Scapinello A, Sartori CA. Autoimmune-like pancreatitis in thymoma with myasthenia gravis. Chir Ital 2002;54:91-94.
  5. Weitzel JN, Pooler PA, Mohammed R, Levitt MD, Eckfeldt JH. A unique case of breast carcinoma producing pancreatic-type isoamylase. Gastroenterology 1988;94:519-520. https://doi.org/10.1016/0016-5085(88)90447-7
  6. Lee HM, Song YG, Park TB, et al. A case of amylase producing small cell lung cancer. Tuberc Respir Dis 1997;44:661-668. https://doi.org/10.4046/trd.1997.44.3.661
  7. Chung HS, Park MS, Kim YS, Kim SK, Chang J, Kim SK. A case of poorly differentiated squamous cell lung cancer with hyperamylasemia. Tuberc Respir Dis 2005;59:674-678. https://doi.org/10.4046/trd.2005.59.6.674
  8. Sakai M, Ishikawa S, Yamamoto T, Onizuka M, Sakakibara Y, Noguchi M. A direct measurement of serum amylase levels produced by lung cancer. Ann Thorac Surg 2005;79:1409-1411. https://doi.org/10.1016/j.athoracsur.2003.10.069
  9. McPherson RA, Pincus MR, Naif Z. Abraham Jr, Robert E. Hutchison. Henry's clinical diagnosis and management by laboratory methods. 21st ed. Philadelphia, PA: Saunders Elsevier, 2006:287-288.
  10. Yanagitani N, Kaira K, Sunaga N, et al. Serum amylase is a sensitive tumor marker for amylase-producing small cell lung cancer? Int J Clin Oncol 2007;12:231-233. https://doi.org/10.1007/s10147-006-0643-9
  11. Lenler-Petersen P, Grove A, Brock A, Jelnes R. Alpha-amylase in resectable lung cancer. Eur Respir J 1994;7:941-945.

Cited by

  1. Amylase-Producing Primary Peritoneal Carcinoma vol.89, pp.3, 2012, https://doi.org/10.3904/kjm.2015.89.3.358